Search results
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 4 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID
Trump, accustomed to friendly crowds, confronts repeated booing during Libertarian convention speech...
The Boston Globe· 2 hours agoTrump tried to praise "fierce champions of freedom in this room" and called President Joe Biden a...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 1 day agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Countries Fail to Agree on Treaty to Prepare the World for the Next Pandemic
New York Times· 1 day agoAmong the sticking points are equitable access to vaccines and financing to set up surveillance...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 3 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
‘Politically calculated’: Trump confronts his RFK Jr. problem on vaccines
Politico via Yahoo News· 7 days agoKennedy Jr. Trump is threatening to “not give one penny” to schools or colleges that mandate the ...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 6 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe consequences ...